We have investigated the immunosuppressive effect of cyclosporiii A (CsA) on delayed-type hypersensitivity (DTH) to syngeneic testicular cells (TC) Cyclosporin A (CsA), a fungal metabolite, is a potent immunosuppressive agent that has specific actions on T cells1*. It is clinically quite useful for prevention of allograft rejection, suppression of graft-vs-host disease after allogeneic bone marrow transplantation, and treatment of certain autoimmune diseases2~4). Many studies have been made, but still there is some uncertainty about the mechanism by which CsA exerts its effect. Studies on testicular autoimmunity are significant for a better understanding of humanmale infertility. Delayed-type hypersensitivity (DTH) has been detected in animals showing experimental autoimmune orchitis (EAO) and is thought to play a key role in the development of the lesion5~7).
We have investigated the immunosuppressive effect of cyclosporiii A (CsA) on delayed-type hypersensitivity (DTH) to syngeneic testicular cells (TC). DTHto syngeneic TC was induced by subcutaneous (sc) immunization with viable syngeneic TCand was augmented by a high dose of cyclophosphamide (CY)-pretreatment. DTHwas suppressed by administration of CsAin a dose-dependent manner. When the mice were immunized alone or with lOOmg/kg of CYpretreatment, 30 mg/kg or more of CsA suppressed DTHto TC. In mice immunized with 200 mg/kg of CY-pretreatment, 50mg/kg of CsA was needed to suppress DTH.
DTH is thought to play a key role in the induction and/or maintenance of experimental autoimmune orchitis (EAO). Our data show that DTHto syngeneic TC induced by immunization is suppressed by administration of CsA. Pretreatment of mice with immunization and administration of CsA suppressed DTH significantly when the mice were challenged with immunization with CY-pretreatment. However, DTHwas rather enhanced significantly in mice pretreated with administration of CsA alone without preimmunization. Therefore, even though administration of CsAwith immunization suppresses DTH, administration of CsA alone might rather eliminate suppressive mechanismresulting in augmentation of DTH.
Cyclosporin A (CsA), a fungal metabolite, is a potent immunosuppressive agent that has specific actions on T cells1*. It is clinically quite useful for prevention of allograft rejection, suppression of graft-vs-host disease after allogeneic bone marrow transplantation, and treatment of certain autoimmune diseases2~4). Many studies have been made, but still there is some uncertainty about the mechanism by which CsA exerts its effect. Studies on testicular autoimmunity are significant for a better understanding of humanmale infertility. Delayed-type hypersensitivity (DTH) has been detected in animals showing experimental autoimmune orchitis (EAO) and is thought to play a key role in the development of the lesion5~7). Yoshida et al.8) and Sakamoto et ql.9) have reported that delayed footpad reaction (DFR) against syngeneic testicular cells (TC) was elicited in male mice immunized subcutaneously (sc) with syngeneic viable TCwithout using adjuvants and the reaction could be augmented by the pretreatment of a high dose of cyclophosphamide (CY). C3H/He mice solely immunized with syngeneic TC developed a slight damage of seminiferous tubules and a moderate degree of EAOwas induced by immunization with lOOmg/kg of CY pretreatment6). Severer EAOwas induced by a booster, reimmunization with TC two weeks later10). Therefore, this kind of immunization model might reflect a clinical immunological testis lesions.
In the present study, we have determined the suppressive effect of CsAon DTHto syngeneic TC induced by immunization with viable syngeneic TC. We also tried to induce the tolerance by preimmunization and administration of CsA. The viable TC of syngeneic mice were used as the immunizing antigen, and for the tolerance experiment, the liver cells of syngeneic mice were used as an exampleof irrelevant antigens. The testes were removed from mice after complete bleeding and squeezed with a plunger in cold Hanks' balanced salt solution (HBSS). Cell suspensions were passed through a Cell Strainer (Becton Dickinson & Company, New Jersey, U.S.A.) to remove residual large fragments. After washing, the cells were resuspended in HBSSand adjusted to designed concentrations after counting viability by the trypan blue exclusion method. The testicular cell suspension contained 20~30%of sperm and spermatids and 70~80%of round-shaped cells. The liver cells were prepared by the same methods as those used for the preparation of TC.
Treatment with CY CY (Endoxan, Shionogi & Co., Japan) was dissolved in phosphate buffered saline (PBS) at a concentration of20 mg/ml and injected intraperitoneally (ip) in a dose of 100 or 200 mg/kg 2 days prior to immunization.
Immunization
Mice were injected sc into the right flank with 1 x 107 of antigenic cells in 0.1 ml of HBSS.
Evaluation of DFR
An eliciting dose of 1 x 106 viable syngeneic TC in a volume of 0.05ml of HBSSwas injected into the sc tissue of the plantar surface of the right hind footpad 6 days after immunization. As a control, 0.05 ml of HBSSwas injected into the left footpad. The degree of swelling was measured 24 hours later with a dial thickness gauge (Peacock, Ozaki Mfg. Co. Ltd., Japan). Reactions were expressed as the difference in thickness between the right and left footpads. The results were expressed as the mean+S.D. of 5 to 10 animals.
Administration of CsA
CsA (Sandimmun, Sandoz Ltd., Japan) was dissolved in PBS and injected ip in a dose of 1, 2, 5, 10, 30 or 50mg/kg for 7 consecutive days starting on the day before immunization.
Tolerance Induction
Mice were preimmunized sc with 1 x 107 viable syngeneic TC or liver cells (irrelevant antigen) or not preimmunized and 50 mg/kg of CsA was administered for 7 consecutive days starting on the day before immunization. Then, the mice were given 100 mg/kg of CYon the final day of CsA administration, followed by sc immunization with syngeneic TC 2 days later. DFRwas measured 6 days after immunization.
Statistics
The statistical significance of the data was determined according to Student's /-test using the values for footpad swelling. A P value of less than 0.05 was taken as significant.
Results
Induction of DFR by sc Immunization and its Augmentation by CY-pretreatment Whenmice were immunized sc with syngeneic TC, significant DFRwas detected (P<0.01). When mice were pretreated with CYof 100 or 200mg/kg, DFRwas enhanced significantly in a dose-dependent manner (P<0.05 and P<0.001, respectively) ( Fig. 1) . Mice were immunized sc with 1 x 107 viable syngeneic TC without CY-pretreatment. CsA of 5, 10 or 30 mg/kg was administered for 7 consecutive days starting on the day before immunization. Footpad elicitation was carried out with 1 x 106 syngeneic TC6 days after immunization.
Suppressive Effect of CsA on DFR Induced by Immunization Alone When the immunized mice were injected with 30mg/kg of CsA for 7 consecutive days, DFRwas suppressed significantly (P<0.05). However, administration of 10 or 5 mg/kg of CsA did not affect DFR (Fig.  2) . Mice were immunized sc with 1 x 107 viable syngeneic TC with pretreatment of lOOmg/kg of CY 2 days before. CsA of 2,10, 30 or 50mg/kg was administered for 7 consecutive days starting on the day before immunization. Footpad elicitation was carried out with 1 x 106 syngeneic TC 6 days after immunization. Mice were immunized sc with 1 x 107 viable syngeneic TC with pretreatment of 200mg/kg of CY 2 days before. CsA of 1, 5, 30 or 50mg/kg was administered for 7 consecutive days starting on the day before immunization. Footpad elicitation was carried out with 1 x 106 syngeneic TC 6 days after immunization.
Suppressive Effect of CsA on DFR Induced by Immunization with lOO mg/kg of CY-pretreatment Mice were immunized with lOO mg/kg of CY-pretreatment. Administration of CsA of 50 or 30 mg/kg significantly suppressed DFR (P<0.001), however, CsA of 10 or 2mg/kg were not effective (Fig. 3) . Mice were preimmunized sc with 1 x 107 viable syngeneic TCor liver cells or not preimmunized and 50 mg/kg of CsA was administered for 7 consecutive days starting on the day before preimmunization. Then, the mice were given 100mg/kg of CYon the final day of CsA administration, followed by sc immunization with syngeneic TC 2 days later. Footpad elicitation was carried out with 1 x 106 syngeneic TC 6 days after immunization.
Suppressive Effect of CsA on DFRInduced by Immunization with 200 mg/kg of CY-pretreatment Whenmice were immunized with 200 mg/kg of CY-pretreatment, only administration of 50 mg/kg of CsA suppressed DFRsignificantly (P=0.001). Administration of 30mg/kg of CsA were not effective on DFRsuppression as well as 5 or 1 mg/kg of CsA (Fig. 4) .
Tolerance Induction by Pretreatment with Immunization and/or Administration of CsA Mice were preimmunized with syngeneic TCand 50 mg/kg of CsAwas administered for 7 consecutive days. Then, the mice were given 100mg/kg of CY, followed by immunization with syngeneic TC 2 days later. DFRwas suppressed significantly in such-treated mice (P=0.001). However, when mice were preimmunized with syngeneic liver cells (irrelevant antigen) or not preimmunized at all and CsA was administered, DFR was rather enhanced significantly in such-treated mice (P< 0.001) (Fig. 5) .
Discussion
Recently, studies on EAOhave been advanced thanks to induction of several murine EAOmodels1°' 1 1). Wehave also reported a simple method for inducing the lesion in C3H/He mice by sc immunization with viable syngeneic TC, especially when the mice were pretreated with 100mg/kg of CY6). Many reports imply that DTHplays an important role in the onset and maintenance of orchitis5'12) In our model, significant DFRwas induced and was augmented by a high dose of CY-pretreatment (Fig. 1) . We have already shownthat this augmentation is due to elimination ofCY-sensitive suppressor T cells for DTH13). CsA is already widely used for prevention of allograft rejection2). CsAis also expected to be very effective in the treatment of organ-specific autoimmune diseases. Hojo et ah have reported that EAOcan VOL.47 NO.6 THE JOURNAL OF ANTIBIOTICS 713 be abrogated by CsA in guinea pigs14). It is quite promising that a pilot study was partly successful in treating autoimmuneinfertile men15). However,there are somequestions to this report. First, the authors defined "autoimmune infertility" based on the presence of serum antisperm antibodies (ASA), ignoring the cellular immunity. Second, even if three out of nine successful pregnancies occurred in the CsA-treated patients, successful conceptions with CsA were unrelated to falls in ASAtiter. Based on the more significance of cellular immunity than humoral immunity in the research of EAO,and also on the more powerful suppressive effect of CsA on cellular immunity than humoral immunity, it may be logical that discrepancy occurred between successful treatment and ASAtiter. Therefore, it seems that more basic studies such as our present one are necessary and significant. Weshould add, however, that it is very promising for the potential clinical use of CsAthat there were very few and minor side effects in the CsA-treated patients comparedwith the report of some serious side effects of corticosteroids-treated patients16).
In the present report, DTH to syngeneic TC induced by sc immunization was suppressed by administration of CsA in a dose-dependent manner. Whenthe mice were immunized with syngeneic TC alone or with 100 mg/kg ofCY-pretreatment, 30 mg/kg or more ofCsA was needed (Figs. 2 and 3) . However, when the mice were immunized with pretreatment of 200mg/kg of CY, 50mg/kg of CsA was necessary (Fig. 4) . Further studies are under way to examine the immunosuppresive effect of CsAon the induction ofEAO.
Wehave tried to induce antigen-specific immunetolerance by immunization and administration of CsA. Pretreatment of mice with immunization and administration of CsAsuppressed DTHsignificantly but not inhibited completely when the mice were challenged with immunization with CY-pretreatment (Fig. 5) . However, it was surprising that DTHwas rather enhanced significantly by pretreatment of mice without immunization or immunization with the third party antigen and administration of CsA. Our tentative explanation for this phenomenonis that administration of CsAwithout the relevant antigen might rather eliminate suppressor T cells, even though administration of CsAwith the relevant antigen eliminate effector T cells for DTH.In regard to this, CsA caused organ-specific autoimmune disease in mice when the drug was administered daily for 1 week to newborns17) and CsA treatment elicited diabetes in a diabetes-resistant substrain of BBrats1 8). Currently, studies are under way to elucidate this mechanism by our local passive transfer system9) and systemic suppression transfer system13).
